Skip to content

EU · EudraLex Vol.4

EU GMP Annex 1 8.82

8. Production and Specific Technologies › Filter sterilisation of products which cannot be sterilised in their final container

Section text

The filtration system should be designed to:

i. Allow operation within validated process parameters.

ii. Maintain the sterility of the filtrate.

iii. Minimize the number of aseptic connections required between the final sterilising grade filter and the final filling of the product.

iv. Allow cleaning procedures to be conducted as necessary.

v. Allow sterilisation procedures, including sterilisation in place, to be conducted as necessary.

vi. Permit in-place integrity testing, of the 0.22 µm final sterilising grade filter, preferably as a closed system, both prior to, and following filtration as necessary. In-place integrity testing methods should be selected to avoid any adverse impact on the quality of the product.

Source: European Commission, DG SANTE · © European Union. Reuse is authorised provided the source is acknowledged (Commission Decision 2011/833/EU on the reuse of Commission documents). · retrieved 2026-11-15

Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.